BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 30986917)

  • 1. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
    Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: impact of anemia and treatment.
    Krzystek-Korpacka M; Neubauer K; Berdowska I; Zielinski B; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2010 Sep; 16(9):1467-75. PubMed ID: 20186929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum adipokines in inflammatory bowel disease.
    Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
    World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered uric acid metabolism in isolated colonic Crohn's disease but not ulcerative colitis.
    Zhu F; Feng D; Zhang T; Gu L; Zhu W; Guo Z; Li Y; Lu N; Gong J; Li N
    J Gastroenterol Hepatol; 2019 Jan; 34(1):154-161. PubMed ID: 29926959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
    Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
    World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
    Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
    J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.
    Koutroubakis IE; Malliaraki N; Dimoulios PD; Karmiris K; Castanas E; Kouroumalis EA
    Dig Dis Sci; 2004 Sep; 49(9):1433-7. PubMed ID: 15481315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
    Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
    Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidative Efficacy of a
    Papada E; Forbes A; Amerikanou C; Torović L; Kalogeropoulos N; Tzavara C; Triantafillidis JK; Kaliora AC
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative Colitis and Crohn's Disease Are Associated with Decreased Serum Selenium Concentrations and Increased Cardiovascular Risk.
    Castro Aguilar-Tablada T; Navarro-Alarcón M; Quesada Granados J; Samaniego Sánchez C; Rufián-Henares JÁ; Nogueras-Lopez F
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27916926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
    Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
    Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
    Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.